• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乙型肝炎病毒核心蛋白对 CD8(+) T 细胞选择压力的适应。

Adaptation of the hepatitis B virus core protein to CD8(+) T-cell selection pressure.

机构信息

Institute of Virology, University of Duisburg-Essen, University Hospital, Essen, Germany.

Department of Gastroenterology and Hepatology, University of Duisburg-Essen, University Hospital, Essen, Germany.

出版信息

Hepatology. 2015 Jul;62(1):47-56. doi: 10.1002/hep.27771. Epub 2015 Mar 25.

DOI:10.1002/hep.27771
PMID:25720337
Abstract

UNLABELLED

Activation of hepatitis B virus (HBV)-specific CD8 T cells by therapeutic vaccination may promote sustained control of viral replication by clearance of covalently closed circular DNA from infected hepatocytes. However, little is known about the exact targets of the CD8 T-cell response and whether HBV reproducibly evades CD8 T-cell immune pressure by mutation. The aim of this study was to address if HBV reproducibly selects substitutions in CD8 T-cell epitopes that functionally act as immune escape mutations. The HBV core gene was amplified and sequenced from 148 patients with chronic HBV infection, and the human leukocyte antigen (HLA) class I genotype (A and B loci) was determined. Residues under selection pressure in the presence of particular HLA class I alleles were identified by a statistical approach utilizing the novel analysis package SeqFeatR. With this approach we identified nine residues in HBV core under selection pressure in the presence of 10 different HLA class I alleles. Additional immunological experiments confirmed that seven of the residues were located inside epitopes targeted by patients with chronic HBV infection carrying the relevant HLA class I allele. Consistent with viral escape, the selected substitutions reproducibly impaired recognition by HBV-specific CD8 T cells.

CONCLUSION

Viral sequence analysis allows identification of HLA class I-restricted epitopes under reproducible selection pressure in HBV core; the possibility of viral escape from CD8 T-cell immune pressure needs attention in the context of therapeutic vaccination against HBV.

摘要

未加标签

治疗性疫苗激活乙型肝炎病毒 (HBV)-特异性 CD8 T 细胞,可能通过清除感染肝细胞中的共价闭合环状 DNA 来促进对病毒复制的持续控制。然而,对于 CD8 T 细胞反应的确切靶点以及 HBV 是否通过突变可重复地逃避 CD8 T 细胞免疫压力,人们知之甚少。本研究旨在探讨 HBV 是否可重复地选择 CD8 T 细胞表位中的取代,这些取代是否具有免疫逃逸突变的功能。从 148 例慢性 HBV 感染患者中扩增和测序 HBV 核心基因,并确定人类白细胞抗原 (HLA) I 类基因型 (A 和 B 基因座)。通过利用新的分析软件包 SeqFeatR 的统计方法,鉴定在特定 HLA I 类等位基因存在下具有选择压力的残基。利用该方法,我们在存在 10 种不同 HLA I 类等位基因的情况下,鉴定出 HBV 核心中的 9 个具有选择压力的残基。额外的免疫实验证实,在携带相关 HLA I 类等位基因的慢性 HBV 感染患者中,有 7 个残基位于被靶向的表位内。与病毒逃逸一致,所选取代物可重复地损害了 HBV 特异性 CD8 T 细胞的识别。

结论

病毒序列分析可鉴定 HBV 核心中具有可重复选择压力的 HLA I 类限制性表位;在针对 HBV 的治疗性疫苗接种背景下,需要注意病毒逃避 CD8 T 细胞免疫压力的可能性。

相似文献

1
Adaptation of the hepatitis B virus core protein to CD8(+) T-cell selection pressure.乙型肝炎病毒核心蛋白对 CD8(+) T 细胞选择压力的适应。
Hepatology. 2015 Jul;62(1):47-56. doi: 10.1002/hep.27771. Epub 2015 Mar 25.
2
CD8 T-Cell Response-Associated Evolution of Hepatitis B Virus Core Protein and Disease Progress.CD8 T 细胞反应相关的乙型肝炎病毒核心蛋白的进化与疾病进展。
J Virol. 2018 Aug 16;92(17). doi: 10.1128/JVI.02120-17. Print 2018 Sep 1.
3
Spatiotemporal Differences in Presentation of CD8 T Cell Epitopes during Hepatitis B Virus Infection.HBV 感染过程中 CD8+T 细胞表位呈现的时空差异。
J Virol. 2019 Feb 5;93(4). doi: 10.1128/JVI.01457-18. Print 2019 Feb 15.
4
Immune-driven adaptation of hepatitis B virus genotype D involves preferential alteration in B-cell epitopes and replicative attenuation--an insight from human immunodeficiency virus/hepatitis B virus coinfection.免疫驱动的乙型肝炎病毒基因型 D 适应性改变涉及 B 细胞表位的优先改变和复制能力减弱——来自人类免疫缺陷病毒/乙型肝炎病毒合并感染的见解。
Clin Microbiol Infect. 2015 Jul;21(7):710.e11-20. doi: 10.1016/j.cmi.2015.03.004. Epub 2015 Apr 13.
5
Identification of HLA-A*0201-restricted CD8+ T-cell epitope C₆₄₋₇₂ from hepatitis B virus core protein.鉴定乙型肝炎病毒核心蛋白中 HLA-A*0201 限制性 CD8+ T 细胞表位 C₆₄₋₇₂。
Int Immunopharmacol. 2012 Jun;13(2):141-7. doi: 10.1016/j.intimp.2012.03.018. Epub 2012 Apr 3.
6
[Direct analysis of HBV-specific CD8+ lymphocyte by tetrameric HLA-A2/core 18-27 complex in chronic Hepatitis B].[采用四聚体HLA-A2/核心18-27复合物直接分析慢性乙型肝炎中HBV特异性CD8 +淋巴细胞]
Taehan Kan Hakhoe Chi. 2002 Jun;8(2):139-48.
7
Selection pressure on the hepatitis B virus pre-S/S and P open reading frames in Tongan subjects with a chronic hepatitis B virus infection.乙型肝炎病毒前 S/S 和 P 开放阅读框在慢性乙型肝炎病毒感染的汤加人群中的选择压力。
Antiviral Res. 2012 Nov;96(2):148-57. doi: 10.1016/j.antiviral.2012.08.007. Epub 2012 Aug 31.
8
Immune escape pathways from the HBV core CD8 T cell response are driven by individual HLA class I alleles.HBV 核心 CD8 T 细胞反应的免疫逃逸途径是由个体 HLA Ⅰ类等位基因驱动的。
Front Immunol. 2022 Nov 10;13:1045498. doi: 10.3389/fimmu.2022.1045498. eCollection 2022.
9
Mutations in Hepatitis D Virus Allow It to Escape Detection by CD8 T Cells and Evolve at the Population Level.肝炎 D 病毒的突变使其能够逃避 CD8 T 细胞的检测,并在群体水平上进化。
Gastroenterology. 2019 May;156(6):1820-1833. doi: 10.1053/j.gastro.2019.02.003. Epub 2019 Feb 12.
10
Core antigen mutations of human hepatitis B virus in hepatomas accumulate in MHC class II-restricted T cell epitopes.肝癌中人类乙型肝炎病毒的核心抗原突变积聚于MHC II类限制性T细胞表位。
Virology. 1995 Sep 10;212(1):151-62. doi: 10.1006/viro.1995.1463.

引用本文的文献

1
Joint host-pathogen genomic analysis identifies hepatitis B virus mutations associated with human NTCP and HLA class I variation.联合宿主-病原体基因组分析鉴定与人类 NTCP 和 HLA Ⅰ类变异相关的乙型肝炎病毒突变。
Am J Hum Genet. 2024 Jun 6;111(6):1018-1034. doi: 10.1016/j.ajhg.2024.04.013. Epub 2024 May 14.
2
Immune escape pathways from the HBV core CD8 T cell response are driven by individual HLA class I alleles.HBV 核心 CD8 T 细胞反应的免疫逃逸途径是由个体 HLA Ⅰ类等位基因驱动的。
Front Immunol. 2022 Nov 10;13:1045498. doi: 10.3389/fimmu.2022.1045498. eCollection 2022.
3
Accumulation of mutations in antibody and CD8 T cell epitopes in a B cell depleted lymphoma patient with chronic SARS-CoV-2 infection.
慢性 SARS-CoV-2 感染的 B 细胞耗竭淋巴瘤患者中抗体和 CD8 T 细胞表位的突变积累。
Nat Commun. 2022 Sep 23;13(1):5586. doi: 10.1038/s41467-022-32772-5.
4
Checkpoint Inhibitors and Therapeutic Vaccines for the Treatment of Chronic HBV Infection.检查点抑制剂和治疗性疫苗治疗慢性乙型肝炎病毒感染。
Front Immunol. 2020 Mar 4;11:401. doi: 10.3389/fimmu.2020.00401. eCollection 2020.
5
Discovery and Selection of Hepatitis B Virus-Derived T Cell Epitopes for Global Immunotherapy Based on Viral Indispensability, Conservation, and HLA-Binding Strength.基于病毒不可或缺性、保守性和HLA结合强度发现和筛选用于全球免疫治疗的乙型肝炎病毒衍生T细胞表位
J Virol. 2020 Mar 17;94(7). doi: 10.1128/JVI.01663-19.
6
Locus 5p13.1 may be associated with the selection of cancer-related HBV core promoter mutations.Locus 5p13.1 可能与选择与癌症相关的 HBV 核心启动子突变有关。
Int J Med Sci. 2019 Jun 10;16(7):990-997. doi: 10.7150/ijms.34297. eCollection 2019.
7
Detection and Characterization of Hepatitis B Virus-Specific CD8 T Cells in Patients Considered Immune Tolerant.在被认为免疫耐受的患者中检测和鉴定乙型肝炎病毒特异性 CD8 T 细胞。
Front Immunol. 2019 Jun 6;10:1319. doi: 10.3389/fimmu.2019.01319. eCollection 2019.
8
Mutations in Hepatitis D Virus Allow It to Escape Detection by CD8 T Cells and Evolve at the Population Level.肝炎 D 病毒的突变使其能够逃避 CD8 T 细胞的检测,并在群体水平上进化。
Gastroenterology. 2019 May;156(6):1820-1833. doi: 10.1053/j.gastro.2019.02.003. Epub 2019 Feb 12.
9
Immunological cure of HBV infection.HBV 感染的免疫治愈。
Hepatol Int. 2019 Mar;13(2):113-124. doi: 10.1007/s12072-018-9912-8. Epub 2019 Jan 2.
10
Insights From Antiviral Therapy Into Immune Responses to Hepatitis B and C Virus Infection.从抗病毒治疗中洞察乙型肝炎和丙型肝炎病毒感染的免疫反应。
Gastroenterology. 2019 Jan;156(2):369-383. doi: 10.1053/j.gastro.2018.08.061. Epub 2018 Sep 26.